Preclinical data often fails to account for aged physiology
We work where human biology meets engineering
Human-relevant aged tissue models
Preclinical service utilizing novel organ-on-chip technology to mimic an aged environment
What do we offer?
Our Services
Our Technology
- Multi-tissue organ-on-chip technology
- Closely mimics human biology
- Accurate artificial aging platform
- Reduced reliance on animal testing
- Highly standardized, reproducible protocol
Comparison of Preclinical Methods
| In vitro 2D Cell Culture | In vivo Animal Model | Microphysiological System | |
|---|---|---|---|
| Human relevance | ✓ | ✕ | ✓ |
| Complex 3D organs and tissues | ✕ | ✓ | ✓ |
| Customizable models | ✕ | ✕ | ✓ |
| Rapid inducible aging | ✕ | ✕ | ✓ |
| Time to result | FAST | SLOW | FAST |
| Throughput | ✓ | ✕ | ✕ |
Founding principles
Decisions should be grounded in systems that mirror human biology.
Our platform enables rapid discovery of vital longevity medicines
Decisions should be based on systems that closely mimic human biology
The future of preclinical research is 100% animal-free
Founding team
People behind the platform
Declan Farriday
CEO, Co-Founder
B.S. Molecular Biology
B.A. Neurobiology
University of California, Berkeley
declanfarriday@berkeley.edu
Dr. Cameron Kato
CSO, Co-Founder
Ph.D. Bioengineering and Biomedical Engineering
University of California, Berkeley & UCSF
ckato@berkeley.edu
Dr. Andreas Stahl
CTO, Co-Founder
Professor of Nutritional Sciences & Toxicology
University of California, Berkeley
astahl@berkeley.edu
Dr. Irina Conboy
Scientific Advisory Board Member
Professor of Bioengineering
University of California, Berkeley
iconboy@berkeley.edu
Previously at
Contact Us
Need to reach out directly? Email declanfarriday@berkeley.edu.